LIU Yao, LI Shan, QIU Ni, HU Yongzhou, CAO Ji, SHENG Rong. Structural Modification and SAR Study of 3-Aryl-5-pyrazol-1,2,4-oxadiazole Derivatives as HIF-1 Inhibitor[J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(10): 1153-1160. DOI: 10.13748/j.cnki.issn1007-7693.2021.10.001
    Citation: LIU Yao, LI Shan, QIU Ni, HU Yongzhou, CAO Ji, SHENG Rong. Structural Modification and SAR Study of 3-Aryl-5-pyrazol-1,2,4-oxadiazole Derivatives as HIF-1 Inhibitor[J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(10): 1153-1160. DOI: 10.13748/j.cnki.issn1007-7693.2021.10.001

    Structural Modification and SAR Study of 3-Aryl-5-pyrazol-1,2,4-oxadiazole Derivatives as HIF-1 Inhibitor

    • OBJECTIVE To design, synthesis and biological evaluation of a series of 3-aryl-5-pyrazol-1,2,4-oxadiazole compounds as HIF-1 inhibitor.METHODS Through systematic modification on the linker and the substituents of phenyl ring, a series of novel target compounds were designed and evaluated HIF-1 inhibitory activity based on 3-aryl-5-para-Cl-benzyl- pyrazole-1,2,4-oxadiazole derivative 8.RESULTS Eighteen compounds exhibited moderate to good HIF-1 inhibitory activity and compound 11m was the most potent HIF-1 inhibitor with IC50 value of 0.35 μmol·L–1.Further biological evaluation of 11m revealed that it could inhibit HIF-1α protein expression and significantly prevented SKOV3 cells hypoxia-driven migration.CONCLUSION The SAR study of 3-aryl-5-pyrazol-1,2,4-oxadiazole derivatives as HIF-1 inhibitor pave the way for the further development of HIF-1 inhibitor.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return